TALIS BIOMEDICAL CORP (TLIS) Institutional Ownership and Insiders Activity
TALIS BIOMEDICAL CORP (TLIS) is widely held by institutional investors, with 1 firm reporting positions valued at approximately $1.11M based on SEC Form 13F filings for the quarter ended December 31, 2023.
Greenlight Capital is the largest disclosed holder, reporting approximately $1.11M in TLIS holdings in its latest filing.
Institutional ownership remains highly concentrated, with Greenlight Capital representing the majority of disclosed value.
Institutional Holders
1
Total Reported Value
$1.11M
Largest Holder
Greenlight Capital
Largest Position
$1.11M
Insider Transactions (90d)
0
Latest Filing Quarter
Q4 2023
New Institutional Positions
0
Funds Exiting Positions
0
Top Institutional Owners
View allInvestorReported Balance
- Greenlight Capital$1.11M
Related TLIS Institutional Insights:
- TLIS 13F Institutional Holders
- TLIS Superinvestors
- TLIS Institutional Ownership Changes
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- TLIS Insider Trading & SEC Form 4 Activity
- TLIS Articles
- Top Institutional Investor Stock Rankings